Keoxifene Evista Raloxifene exerts its effects by antagonizing the estrogen receptor in some tissues, and agonizing it in others. In this way, certain estrogenic pathways are activated and others are blockaded. It seems to exert estrogenic effects on blood lipids, reducing LDL and total cholesterol, as well as estrogenic effects on bone, improving density. It would also appear to exert anti-estrogenic effects in breast tissue, displacing the traditional effects of estrogen, effectively helping prevent breast cancer in postmenopausal women.
Although Keoxifene Evista Raloxifene was only approved for the treatment of osteoperosis in women, it has potential indications in the use of breast cancer prevention and secondary treatment. However, as with most SERMs, it’s possible use has also been explored in men for a variety of conditions.
Unlike Nolvadex Tamoxifen which causes a very significant raise in testosterone levels, Raloxifene only causes a 20% increase . Thus, for Post Cycle purposes, it probably can not be relied on. For preventing Gynecomasia, it may be as good as other SERMs.
Keoxifene Evista Raloxifene is a relatively new drug to the performance enhancement scene. As a result very few people have actually experimented with it. The few bodybuilders who have actually used it typically compare it to the more commonplace SERM known as Nolvadex Tamoxifen Since it’s relatively new, it’s not widely available to most people and therefore has not yet gotten the widespread acceptance that other similar medications have gotten. However, with respect to this drugs potential, it could be potentially as useful as either Nolvadex or Clomid Clomiphene Citrate as an estrogen agonist/antagonist. As a testosterone booster, I have my doubts.